Dachaigh › Aillse a' bhroilleach › Connecticut › Bridgeport
Sgrùdaidhean clionaigeach Aillse a' bhroilleach ann an Bridgeport, CT
Tha 21 sgrùdaidhean airson Aillse a' bhroilleach a’ lorg phàirtichean aig làraichean ann agus timcheall air Bridgeport (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Stony Brook University Medical Center, Stony Brook · 18 mìle air falbh
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
A’ fastadhÌre 3
- Stony Brook University-Cancer Center ( Site 0034), Stony Brook · 18 mìle air falbh
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
A’ fastadhÌre 3
- Research Site, Stony Brook · 18 mìle air falbh
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
A’ fastadhÌre 3
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · 4 mìle air falbh
- Smilow Cancer Hospital Care Center - Fairfield, Fairfield · 5 mìle air falbh
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
A’ fastadh
- Stony Brook Cancer Center, Stony Brook · 18 mìle air falbh
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
A’ fastadhÌre 1/2
- Stony Brook University Hospital, Stony Brook · 18 mìle air falbh
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
A’ fastadhÌre 3
- Stony Brook University Medical Center, Stony Brook · 18 mìle air falbh
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A’ fastadhÌre 3
- Stony Brook University Cancer Center, Stony Brook · 18 mìle air falbh
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
A’ fastadhÌre 3
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Port Jefferson Station2), Port Jefferson Station · 19 mìle air falbh
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1), Port Jefferson Station · 19 mìle air falbh
- New York Cancers & Blood Specialists, Port Jefferson Station · 19 mìle air falbh
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
A’ fastadhÌre 3
- Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mìle air falbh
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mìle air falbh
- agus 1 a bharrachd
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
A’ fastadhÌre 2
- Stony Brook Cancer Center, Stony Brook · 18 mìle air falbh
ATEMPT 2.0: Adjuvant T-DM1 vs TH
A’ fastadhÌre 2
- Smilow Cancer Hospital Care center at Trumbull, Trumbull · 4 mìle air falbh
- Smilow Cancer Hospital Care center at Fairfield, Fairfield · 5 mìle air falbh
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
A’ fastadhÌre 1
- New York Cancer and Blood Specialists, Port Jefferson Station · 19 mìle air falbh
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
A’ fastadhÌre 3
- Stony Brook University Cancer Center, Stony Brook · 18 mìle air falbh
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
A’ fastadhÌre 3
- Smilow Cancer Hospital - Fairfield, Fairfield · 5 mìle air falbh
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
A’ fastadhÌre 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mìle air falbh
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mìle air falbh
- Stony Brook University Medical Center, Stony Brook · 18 mìle air falbh
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
A’ fastadhSgrùdadh amharc
- Stony Brook Medicine, Stony Brook · 18 mìle air falbh
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
A’ fastadhÌre 1 tràth
- Stony Brook Breast Center, Stony Brook · 18 mìle air falbh
Definitive Radiation Therapy for Inoperable Breast Cancer
A’ fastadh
- Stony Brook University Cancer Center, Stony Brook · 18 mìle air falbh
Definitive Radiation for High-Risk Spine Metastases
A’ fastadhÌre 2
- Stony Brook University Hospital, Stony Brook · 18 mìle air falbh
CtDNA Based MRD Testing for NAC Monitoring in TNBC
A’ fastadhSgrùdadh amharc
- Stony Brook University Cancer Center, Stony Brook · 18 mìle air falbh
Sgrùdaidhean Aillse a' bhroilleach ann am bailtean eile
- New York City, NY136 sgrùdaidhean
- Houston, TX126 sgrùdaidhean
- Boston, MA112 sgrùdaidhean
- Nashville, TN81 sgrùdaidhean
- Los Angeles, CA73 sgrùdaidhean
- Edison, NJ68 sgrùdaidhean
- St. Louis, MO64 sgrùdaidhean
- Queens, NY64 sgrùdaidhean
- Durham, NC64 sgrùdaidhean
- Chicago, IL59 sgrùdaidhean
- Philadelphia, PA56 sgrùdaidhean
- Dallas, TX55 sgrùdaidhean
Sgrùdaidhean eile ann an Bridgeport
- Aillse Sgamhain Neo-chealla-beag14 sgrùdaidhean
- Ailseachadh nan Sgamhan13 sgrùdaidhean
- Leukemia myeloid geur12 sgrùdaidhean
- Galarachd Cardiovasculach9 sgrùdaidhean
- Aillse (gach seòrsa)8 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil8 sgrùdaidhean
- Ailse metastatach7 sgrùdaidhean
- Fàilligeadh a' Chridhe7 sgrùdaidhean
- Aneurysm eanchainn6 sgrùdaidhean
- Myeloma iomaill6 sgrùdaidhean
- Aillse Prostata6 sgrùdaidhean
- Cancer Ovarian5 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.